EDAN Forays into Molecular Point-of-Care Market with Its First-Ever Molecular Diagnostics Solution Released at Medlab Asia 2022
Bangkok [Thailand], October 19 (ANI/PRNewswire): EDAN Instruments, Inc. (300206.SZ) showcased its first molecular diagnostics analysis system, ClariLight CL30, at Medlab Asia & Asia Health 2022, announcing its start of a new segment in diagnostics applications. On this ASEAN region's leading exhibition, CL30 made its worldwide debut at Booth 6.D19, and a series of live demonstrations were held at IMPACT Exhibition Center, Bangkok, Thailand, Oct 19-21. "The advent of ClariLight CL30 scales up our product portfolio in diagnostics applications. As the fastest-growing segment of In-Vi...
Source: laosnews.net